Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Cancer Discov. 2011 Oct;1(5):391–407. doi: 10.1158/2159-8290.CD-11-0209

Table 1.

Types of ncRNAs known in humans

Category Name Quality of supporting data Specific role in carcinogenesis Aberration in cancer Reference
Housekeeping RNAs Transfer RNAs High No No 10, 11
Ribosomal RNAs High No No 10, 11
Small nucleolar RNAs High No No 10, 11
Small nuclear RNAs High No No 10, 11
Small ncRNAs (200 bp or less in size) MicroRNAs High Yes Amplification, deletion, methylation, gene expression 12, 13
Tiny transcription initiation RNAs High Not known Not known 11
Repeat associated small interfering RNAs High Not known Not known 11
Promoter-associated short RNAs High Not known Not known 4, 6, 11
Termini-associated short RNAs High Not known Not known 4, 6, 11
Antisense termini associated short RNAs High Not known Not known 6, 10
Transcription start site antisense RNAs Moderate Not known Not known 10
Retrotransposon-derived RNAs High Not known Not known 15
3’UTR-derived RNAs Moderate Not known Not known 10
Splice-site RNAs Poor Not known Not known 11
Long ncRNA (over 200 bp in size) Long or large intergenic ncRNAs High Yes Gene expression, translocation 7-9, 25, 101
Transcribed ultraconserved regions High Yes Gene expression 18, 19
Pseudogenes High Yes Gene expression, deletion 15, 81
Enhancer RNAs High Yes Not known 17, 29
Repeat-associated ncRNAs High Not known Not known 15
Long intronic ncRNAs Moderate Not known Not known 10, 11
Antisense RNAs High Yes Gene expression 14
Promoter-associated long RNAs Moderate Not known Not known 4
Long stress-induced non-coding transcripts Moderate Yes Gene expression 10, 11